# In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive Care Unit

> **NCT07230041** · — · RECRUITING · sponsor: **Niguarda Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DIAGNOSTIC_TEST:** Liquid Chromatography - Tandem Mass Spectrometry

## Key facts

- **NCT ID:** NCT07230041
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2025-12-15
- **Final completion:** 2026-08-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07230041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07230041, "In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive Care Unit". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07230041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*